North America Enteral Syringe Market Size, Share & Trends Analysis Report by Age Group (Adults and Pediatrics), End User (Hospitals, Ambulatory Surgical Centers, and Homecare), Type (Disposable and Reusable), Country and Growth Forecast, 2024-2031

The North America Enteral Syringe Market is projected to witness market growth of 4.5% CAGR during the forecast period (2024-2031).

The US market dominated the North America Enteral Syringe Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $136.55 millions by 2031. The Canada market is experiencing a CAGR of 6.1% during 2024-2031. Additionally, the Mexico market would exhibit a CAGR of 5.3% during 2024-2031.



These syringes are vital tools in medical practice, designed to administer nutrition, medications, and fluids directly into the gastrointestinal tract. One of the primary applications of these syringes is to provide nutritional support to patients who cannot consume food orally. These syringes are used in various clinical scenarios, each catering to specific patient needs. Conditions such as dysphagia, often caused by neurological disorders like stroke or neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), impair a patient’s ability to swallow.

Individuals undergoing cancer treatments like chemotherapy or radiation therapy may experience nausea, vomiting, or difficulty swallowing. These syringes enable the administration of specialized enteral feeds that meet their nutritional needs despite these challenges. Critically ill patients in intensive care units (ICUs) may require enteral feeding due to their inability to eat normally. Providing sufficient nutrition through these syringes supports their recovery and overall health.

Many Canadians with diabetes experience complications such as gastroparesis, which impairs the stomach's ability to empty properly. These syringes are used to deliver nutritional formulas directly into the gastrointestinal tract, bypassing oral intake challenges. Cancer patients frequently suffer from symptoms like nausea and difficulty swallowing due to treatments like chemotherapy. These syringes are critical for administering nutrients and medications when oral intake is not feasible. Severe cardiovascular conditions may affect appetite or swallowing ability. These syringes help ensure that these patients receive the necessary nutrients and medications when they cannot eat or drink normally. According to Statistics Canada, 45.1% of Canadians lived with at least one major chronic disease in 2021. Almost 2.5 million Canadians reported unmet healthcare needs in 2021. Hence, the high prevalence of the chronic diseases in the region is driving the growth of the market.

Based on Age Group, the market is segmented into Adults and Pediatrics. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Homecare. Based on Type, the market is segmented into Disposable and Reusable. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Boston Scientific Corporation
• Nestlé S.A.
• Fresenius SE & Co. KGaA
• Becton, Dickinson and Company
• Braun Melsungen AG
• Cardinal Health, Inc.
• Moog Inc.
• Cook Medical, Inc.(Cook Group)
• Thermo Fisher Scientific Inc.
• Medela AG

Market Report Segmentation

By Age Group

• Adults
• Pediatrics

By End User

• Hospitals
• Ambulatory Surgical Centers
• Homecare

By Type

• Disposable
• Reusable

By Country

• US
• Canada
• Mexico
• Rest of North America